YEM Search

Plant Summary

Plant Information

TCMBank_ID:	TCMBANKHE000810
ID:	TCMBANKHE000810
植物拉丁名:	Radix Zanthoxyli
功能与主治:	To promote the flow of qi, relieve pain, to eliminate blood stasis, to promote blood circulation and dispel wind./Treatment of traumatic injury, rheumatic arthralgia, stomach-ache, teethache, bitten by venomous snake, applied for burn caused by hot liquid or fire.
药用植物名:	两面针
药味:	Mild; Pungent; Bitter
经络:	Stomach; Liver
毒性:	Toxic
治疗类型:	祛风湿散寒药
TCM_ID_id:	7091
SymMap_id:	245
TCMSP_id:	454

植物对应的化合物

化合物ID	化合物名	别名	分子式	分子质量	Smiles

TCMBANKIN000097	nitidine	I14-18057; CHEMBL176008; 6872-57-7; 933301178Z; NCI60_000995; CTK5C8373; CHEBI:7578; FT-0686666; ZINC898732; SCHEMBL8014101; C09595; AK608233; 2,3-Dimethoxy-12-methyl-9H-phenanthridino[4',3'-2,1]benzo[4,5-d]1,3-dioxolane; N2626; 16,17-DIMETHOXY-21-METHYL-5,7-DIOXA-21-AZAPENTACYCLO[11.8.0.0(2),(1)?.0?,?.0(1)?,(1)?]HENICOSA-1(13),2(10),3,8,11,14(19),15,17,20-NONAEN-21-IUM; Nitidine; Nitidine chloride; AKOS015904022; NCIMech_000542; (1,3)Benzodioxolo(5,6-c)phenanthridinium, 2,3-dimethoxy-12-methyl-; 13063-04-2 (CHLORIDE); Ambap13063-04-2; AJ-24283; AC1L1IB4; broussopapyrine A; UNII-933301178Z; ZB015155; CCG-35985; DTXSID60218846; [1,3]Dioxolo[4',5':4,5]benzo[1,2-c]phenanthridinium,2,3-dimethoxy-12-methyl-; AC1Q701O; 2,3-dimethoxy-12-methyl-[1,3]benzodioxolo[5,6-c]phenanthridin-12-ium; Neuro_000081; BDBM50017566	C21H18NO4+	348.4 g/mol	C[N+]1=CC2=CC(=C(C=C2C3=C1C4=CC5=C(C=C4C=C3)OCO5)OC)OC
TCMBANKIN000295	8-(2'a cyclohexanone)a 7,8-dihydro celandine red base
TCMBANKIN000635	sparteine	EBD2202131; DSSTox_CID_3591; 298897D62S; AK122435; NCGC00142614-01; 90-39-1; RL05684; (7S,7aS,14S,14aR)-dodecahydro-7,14-methano-2H,6H-dipyrido[1,2-a:1',2'-e][1,5]diazocine; L-SPARTEINE; Ambotz90-39-1; Sparteina; 7,14-methano-2H,6H-dipyrido[1,2-a:1',2'-e][1,5]diazocine, dodecahydro-, (7S,7aR,14S,14aS)-; C10783; InChI=1/C15H26N2/c1-3-7-16-11-13-9-12(14(16)5-1)10-17-8-4-2-6-15(13)17/h12-15H,1-11H2/t12?,13?,14-,15-/m0/s; (7S,7aR,14S,14aS)-Dodecahydro-7,14-methano-2H,6H-dipyrido[1,2-a:1',2'-e][1,5]diazocine; Esparteina; CAS-90-39-1; ST24033390; TL8005816; Spartein; ZINC1408502; AJ-67273; CS-W012901; Alkyl Polyglucoside; KS-00000OBL; Sparteinum; UNII-298897D62S; 6-beta,7-alpha,9-alpha,11-alpha-Pachycarpine; MLS002207055; KB-209108; CHEMBL1908847; 7,14-Methano-2H,6H-dipyrido(1,2-a:1',2'-e)(1,5)diazocine, dodecahydro-, (7S-(7alpha,7aalpha,14alpha,14abeta))-; AC1LVZQY; Sparteinum [INN-Latin]; Alkylamphopropionate; 7,14-Methano-2H,6H-dipyrido[1,2-a:1',2'-e][1,5]diazocine, dodecahydro-, [7S-(7alpha,7aalpha,14alpha,14abeta)]-; AKOS016012217; FT-0080874; 6beta,7alpha,9alpha,11alpha-Pachycarpine; Sparteine (-); (6''R'',8''S'',10''R'',12''S'')-7,15-diazatetracyclo[7.7.1.02,7.010,15]heptadecane; MLS000028889; NCGC00181124-02; (-)-Sparteine, >=98.0% (GC); Sparteina [DCIT]; Esparteina [INN-Spanish]; 7,14-Methano-2H,6H-dipyrido(1,2-a:1',2'-e)(1,5)diazocine, dodecahydro-; Sparteine [INN]; CHEBI:28827; (+)-Spartein; DSSTox_RID_77098; DSSTox_GSID_23591; (-)sparteine; Prestwick3_000618; lupinidine; 7,14-Methano-2H,6H-dipyrido[1,2-a:1',2'-e][1,5]diazocine,dodecahydro-, (7S,7aR,14S,14aS)-; SCHEMBL79043; (-)-Sparteine; [7S-(7alpha,7aalpha,14alpha,14abeta)]-Dodecahydro-7,14-methano-2H,6H-dipyrido[1,2-a:1',2'-e][1,5]diazocine; BPBio1_000612; Prestwick_426; (-)-Lupinidine; HMS2096L18; (-) sparteine; Sparteine; (7S,7aR,14S,14aS)-Tetradecahydro-7,14-methanodipyrido[1,2-a:1',2'-e][1,5]diazocine; Lupinidin; NCGC00016346-01; SMR000059203; Tox21_110386_1; EINECS 201-988-8; Genisteine Alkaloid; Sparteine (6CI,8CI); BSPBio_000556; SLRCCWJSBJZJBV-ZQDZILKHSA-N; Tox21_110386; AC1LD8G5	C15H26N2	234.38 g/mol	C1CCN2CC3CC(C2C1)CN4C3CCCC4
TCMBANKIN001244	Iso anise prime
TCMBANKIN001369	1,3-0112(8-dihydrotestosterone nitidine)acetone
TCMBANKIN003371	8-Methoxyiso-decarine		C20H15NO5	349.3 g/mol	COC1=C(C2=C(N=C3C(=C2C=C1)C=CC4=CC5=C(C=C43)OCO5)OC)O
TCMBANKIN005571	5,7-dihydroxy-2',3',4',5 ',6'-pentamethoxyflavone		C20H20O9		COC1=C(C(=C(C(=C1OC)OC)OC)OC)C2=CC(=O)C3=C(C=C(C=C3O2)O)O
TCMBANKIN005956	1-Asarinine	Spectrum2_000811; KBio2_004604; 133-03-9; ACon1_000986; Spectrum4_001725; KBio3_002243; KBio2_002036; TNP00112; SDCCGMLS-0066831.P001; KBio2_007172; KBio1_001998; Spectrum5_000490; SpecPlus_000958; Spectrum3_001162; Spectrum_001556; BSPBio_002743; KBioGR_002110; SPECTRUM1504180; KBioSS_002036; 5-[(1R,3aR,4S,6aR)-4-(1,3-benzodioxol-5-yl)-1,3,3a,4,6,6a-hexahydrofuro[4,3-c]furan-1-yl]-1,3-benzodioxole; NSC 31773; AI3-21202; DivK1c_007054; MEGxp0_001224; 1,3-Benzodioxole, 5,5'-(tetrahydro-1H,3H-furo(3,4-c)furan-1,4-diyl)bis-, (+)-; SPBio_000701; AI3-00810; 133-05-1; NCGC00017230-01; 1,3-Benzodioxole, 5,5'-(tetrahydro-1H,3H-furo(3,4-c)furan-1,4-diyl)bis-, (1alpha,3a alpha,4beta,6a alpha)-	C20H18O6	354.35	C1C2C(COC2C3=CC4=C(C=C3)OCO4)C(O1)C5=CC6=C(C=C5)OCO6
TCMBANKIN006542	glucosyringicacid	gluco-syringic acid; glucosyringic acid	C15H20O10	360.31 g/mol	COC1=CC(=CC(=C1OC2C(C(C(C(O2)CO)O)O)O)OC)C(=O)O
TCMBANKIN007400	D-Episesamin
TCMBANKIN009680	oxypaeoniflorin_qt		C23H28O12	496.46
TCMBANKIN010603	Dihydronitidine	NITIDINE, DIHYDRO; 13063-06-4; (1,3)Benzodioxolo(5,6-c)phenanthridine, 12,13-dihydro-2,3-dimethoxy-12-methyl-; NSC254666; Nitidine, dihydro-; [1,3]Benzodioxolo[5,6-c]phenanthridine, 12,13-dihydro-2,3-dimethoxy-12-methyl-	C21H19NO4	349.38	CN1CC2=CC(=C(C=C2C3=C1C4=CC5=C(C=C4C=C3)OCO5)OC)OC
TCMBANKIN011656	toddaline	chelerythrine; toddaline	C21H18NO4+	348.4 g/mol	C[N+]1=C2C(=C3C=CC(=C(C3=C1)OC)OC)C=CC4=CC5=C(C=C42)OCO5
TCMBANKIN012046	8-Methoxysangu inarine		C21H16NO5+	362.4 g/mol	C[N+]1=C2C(=C3C=CC4=C(C3=C1OC)OCO4)C=CC5=CC6=C(C=C52)OCO6
TCMBANKIN012097	epi-Zanthomuurolanine		C37H45NO5	583.8 g/mol	CC(C)C1CCC(C2C1C=C(CC2)CC3C4=C(C=CC(=C4OC)OC)C5=C(N3C)C6=CC7=C(C=C6C=C5)OCO7)(C)OC
TCMBANKIN012139	epi-Zanthocadinanine B		C37H45NO5	583.8 g/mol	CC(C)C1CCC(C2C1C=C(CC2)CC3C4=C(C=CC(=C4OC)OC)C5=C(N3C)C6=CC7=C(C=C6C=C5)OCO7)(C)OC
TCMBANKIN012176	amaranthin		C30H34N2O19	726.59	C1C(NC(=CC1=CC=[N+]2C(CC3=CC(=C(C=C32)O)OC4C(C(C(C(O4)CO)O)O)OC5C(C(C(C(O5)C(=O)O)O)O)O)C(=O)[O-])C(=O)O)C(=O)O
TCMBANKIN013315	Stigmast-9(11)-en-3-ol		C29H50O	414.7 g/mol	CCC(CCC(C)C1CCC2C1(CC=C3C2CCC4C3(CCC(C4)O)C)C)C(C)C
TCMBANKIN016229	Norchelerythrine	norchelerythrine; 6900-99-8; C12226; ZINC00900935; (1,3)Benzodioxolo(5,6-c)phenanthridine, 1,2-dimethoxy-	C20H15NO4	333.34	COC1=C(C2=CN=C3C(=C2C=C1)C=CC4=CC5=C(C=C43)OCO5)OC
TCMBANKIN016553	Asiatic lactone
TCMBANKIN018326	haplopine	AC1Q6BZM; TimTec1_005697; ST083386; Oprea1_418227; ZINC5998737; AC1L4WKL; HMS1550C21; 1363-10-6; 4,8-dimethoxy-furo[2,3-b]quinolin-7-ol, AldrichCPR; MLS001049015; AKOS032948939; HMS3561H11; AIDS-342575; Oprea1_182538; A835051; STK762192; 7-Hydroxy-8-methoxydictamnine; 9509AF; MCULE-1281961921; CTK5A8833; AIDS342575; C10694; 4,8-dimethoxyfuro[2,3-b]quinolin-7-ol; Heliparvifoline; CHEMBL400257; Bio-0229; BAS 00513816; MolPort-001-898-934; 4,8-dimethoxyfuro[2,3-b]quinolin-7(9h)-one; 4,8-dimethoxy-9H-furo[2,3-b]quinolin-7-one; ZINC00083885; SCHEMBL15263337; 5876-17-5; 4,8-Dimethoxy-furo[2,3-b]quinolin-7-ol; Furo[2,3-b]quinoline, 4,8-dimethoxy-7-hydroxy-; AKOS000635187; CHEMBL455007; 4,8-dimethoxyfurano[2,3-b]quinolin-7-ol; CHEBI:5620; HMS2270N15; SMR000387023; Furo(2,3-b)quinolin-7-ol, 4,8-dimethoxy-; A2194/0092285; Haplopine	C13H11NO4	245.23	COC1=C2C=COC2=NC3=C1C=CC(=C3OC)O
TCMBANKIN018452	everninicacid methyl ester 2-o-β-xylopyra-nosyl-(1→6)-β-glucopyranoside		C21H30O13
TCMBANKIN018655	Zanthocadinanine B		C37H45NO5	583.8 g/mol	CC(C)C1CCC(C2C1C=C(CC2)CC3C4=C(C=CC(=C4OC)OC)C5=C(N3C)C6=CC7=C(C=C6C=C5)OCO7)(C)OC
TCMBANKIN018721	3-[(2R)-2,3-dihydroxy-3-methyl-butyl]-4-methoxy-1-methyl-carbostyril	3-[(2R)-2,3-dihydroxy-3-methylbutyl]-4-methoxy-1-methylquinolin-2-one; 3-[(2R)-2,3-dihydroxy-3-methyl-butyl]-4-methoxy-1-methyl-quinolin-2-one; 2(1H)-Quinolinone, 3-(2,3-dihydroxy-3-methylbutyl)-4-methoxy-1-methyl-, (R)-; 27495-36-9; 3-[(2R)-2,3-dihydroxy-3-methylbutyl]-4-methoxy-1-methyl-2-quinolinone	C16H21NO4	291.34	CC(C)(C(CC1=C(C2=CC=CC=C2N(C1=O)C)OC)O)O
TCMBANKIN018868	Asiatic ketolide
TCMBANKIN020515	rhododendrin		C16H24O7	328.36 g/mol	CC(CCC1=CC=C(C=C1)O)OC2C(C(C(C(O2)CO)O)O)O
TCMBANKIN021308	rhmotoxin,rtx	rhmotoxin, rtx
TCMBANKIN022132	Dihydrochelerythrine	AIDS106788; 17,18-DIMETHOXY-21-METHYL-5,7-DIOXA-21-AZAPENTACYCLO[11.8.0.0(2),(1)?.0?,?.0(1)?,(1)?]HENICOSA-1,3,8,10,12,14(19),15,17-OCTAENE; AKOS032948894; AIDS-106788; 1,2-dimethoxy-12-methyl-13H-[1,3]benzodioxolo[5,6-c]phenanthridine; CTK5C8487; AC1Q703V; 1,2-Dimethoxy-12-methyl-12,13-dihydro-[1,3]dioxolo[4',5':4,5]benzo[1,2-c]phenanthridine; [1,3]Benzodioxolo[5,6-c]phenanthridine,12,13- dihydro-1,2-dimethoxy-12-methyl-; 3arw; CHEMBL400359; 3037AH; ZINC04716567; DTXSID70218913; (1,3)Benzodioxolo(5,6-c)phenanthridine, 12,13-dihydro-1,2-dimethoxy-12-methyl-; ZINC4716567; 4CN-2633; HY-N0903; AC1LABLI; dihydrochelerythrine; 3as1; 1,2-dimethoxy-12-methyl-12,13-dihydro[1,3]benzodioxolo[5,6-c]phenanthridine; 12,13-Dihydrochelerythrine; 6880-91-7; MolPort-000-165-434; CS-3820; SCHEMBL3864468	C21H19NO4	349.38	CN1CC2=C(C=CC(=C2OC)OC)C3=C1C4=CC5=C(C=C4C=C3)OCO5
TCMBANKIN022206	isopimpinellin	4,9-Dimethoxy-furo[3,2-g]chromen-7-one; 7H-Furo(3,2-g)(1)benzopyran-7-one, 4,9-dimethoxy- (8CI); isopimpinellin ; MLS000876836; KBioSS_001104; Isopimpinellin, analytical standard; NCGC00095569-02; SR-01000778471-2; NSC 401288; BRD-K72253829-001-02-8; NCI60_003765; 5,9-dimethoxy-2H-furo[3,2-g]chromen-2-one; NSC401288; 7H-Furo[3,2-g][1]benzopyran-7-one,4,9-dimethoxy-; 4CN-1065; 5, 8-Dimethoxypsoralene; 7H-Furo[3,2-g][1]benzopyran-7-one, 4,9-dimethoxy-; SpecPlus_000154; KBio3_002204; 5,9-Dimethoxypsoralen; DFMAXQKDIGCMTL-UHFFFAOYSA-N; ST5308983; UNII-20GCF755G6; SMR000440593; BSPBio_002704; 4,9-dimethoxyfuro[3,2-g]chromen-7-one; 7H-Furo[3, 4,9-dimethoxy-; NSC217988; BRD-K72253829-001-03-6; 5,8-dimethoxypsoralen; DivK1c_006250; NSC-217988; CHEMBL140796; CHEBI:28853; Spectrum4_001442; I14-13386; SPECTRUM300012; TR-031106; Oprea1_593894; NSC-401288; InChI=1/C13H10O5/c1-15-10-7-3-4-9(14)18-12(7)13(16-2)11-8(10)5-6-17-11/h3-6H,1-2H3; SR-01000778471; C-14994; 4,9-Dimethoxy-7H-furo[3,2-g]chromen-7-one; KBio1_001194; Spectrum3_001232; Dimethylpsoralen; ZINC00314951; CCRIS 4347; Q-100529; ZB010380; KBio2_003672; 4,9-dimethoxy-7-furo[3,2-g]chromenone; HMS2270M12; 4,9-Dimethoxy-7H-furo(3,2-G) (1)benzopyran-7-one; NCGC00095569-01; KBioGR_001923; W1277; MFCD00017407; AN-45204; LS-70709; CC-29668; MEGxp0_000706; DFMAXQKDIGCMTL-UHFFFAOYSA-; ACon1_002361; 482-27-9; CTK4J0725; MolPort-000-882-064; C02162; SC-97796; CCG-38585; MCULE-5163280216; AKOS000278000; ST50308983; SDCCGMLS-0066520.P001; 7H-Furo(3,2-g)(1)benzopyran-7-one, 4,9-dimethoxy- (8CI)(9CI); BDBM50361386; Spectrum_000624; Spectrum2_000308; NSC 217988; STK368476; KBio2_001104; 20GCF755G6; Isopimpinellin (4,9-Dimethoxypsoralen); 5,9-dimethoxyfurano[3,2-g]chromen-2-one; 5,8-Dimethoxy-6,7-furanocoumarin; 4,9-Dimethoxy-7H-furo[3,2-g]chromen-7-one #; DTXSID30197457; FT-0603412; 4,9-Dimethoxy-7H-furo[3,2-g][1]benzopyran-7-one; I0861; BAS 00704724; Oprea1_132007; 4,9-Dimethoxyfuro[3,2-g]benzopyran-7-one; AC1Q6AY5; Spectrum5_000023; AC1L28ZK; Isopimpinellin; SPBio_000276; 5,8-Dimethoxypsoralene; 4,9-Dimethoxy-7-oxofuro[3,2-g]chromene; 5,8-Dimethoxypsoralen; SCHEMBL498907; AG-667/03555034; 4,9-Dimethoxy-7H-furo[3,2-g][1]benzopyran-7-one, 9CI; KBio2_006240; ZINC314951; NCGC00095569-03	C13H10O5	246.22	COC1=C2C=COC2=C(C3=C1C=CC(=O)O3)OC
TCMBANKIN022566	Diosphenol	SCHEMBL873797; C09854; EINECS 207-704-9; AC1L2WHG; AC1Q6D64; QSIMLPCPCXVYDD-UHFFFAOYSA-N; Buchu camphor; 1-p-menthen-2-ol-3-one; CTK8I8590; LMPR0102090061; Barosma camphor; AKOS022505068; 2-Cyclohexen-1-one, 2-hydroxy-3-methyl-6-(1-methylethyl)-; DTXSID5052127; diosphenol; Buccocamphor; AN-21384; 2-hydroxy-3-methyl-6-propan-2-ylcyclohex-2-en-1-one; 2-Hydroxy-6-isopropyl-3-methyl-2-cyclohexen-1-one; 2-Hydroxy-6-isopropyl-3-methyl-2-cyclohexen-1-one #; 2-hydroxy-3-methyl-6-(propan-2-yl)cyclohex-2-en-1-one; 2-hydroxy-6-isopropyl-3-methyl-cyclohex-2-en-1-one; 2-Hydroxypiperitone; 490-03-9; CHEBI:4632; 2-Hydroxy-6-(isopropyl)-3-methylcyclohex-2-en-1-one	C10H16O2	168.23	CC1=C(C(=O)C(CC1)C(C)C)O
TCMBANKIN024016	Arnottianamide	Formamide, N-(6-(2-hydroxy-3,4-dimethoxyphenyl)naphtho(2,3-d)-1,3-dioxol-5-yl)-N-methyl-; arnottianamide; N-[7-(2-hydroxy-3,4-dimethoxy-phenyl)benzo[f][1,3]benzodioxol-8-yl]-N-methyl-formamide; N-[7-(2-hydroxy-3,4-dimethoxy-phenyl)benzo[f][1,3]benzodioxol-8-yl]-N-methyl-methanamide; N-[7-(2-hydroxy-3,4-dimethoxyphenyl)-8-benzo[f][1,3]benzodioxolyl]-N-methylformamide; ZINC04716569; 60394-88-9; N-[7-(2-hydroxy-3,4-dimethoxyphenyl)benzo[f][1,3]benzodioxol-8-yl]-N-methylformamide	C21H19NO6	381.38	CN(C=O)C1=C(C=CC2=CC3=C(C=C21)OCO3)C4=C(C(=C(C=C4)OC)OC)O
TCMBANKIN024231	2,6-dimethyl lanisole
TCMBANKIN025514	Thalidomide new rod pepper(Sansho hormone)
TCMBANKIN026717	sparassol	methyl 4-methoxy-6-methyl-salicylate; Spectrum2_000404; UNII-49LGW9K0EH; CHEBI:92544; Spectrum5_001794; Sparassol; 520-43-4; Methyl 2-hydroxy-4-methoxy-6-methylbenzoate; PFVPJOAAHSOENR-UHFFFAOYSA-N; AKOS000278016; KBioGR_001562; Sparassol [MI]; SPECTRUM210924; Spectrum4_000951; BG01204997; SPBio_000328; 49LGW9K0EH; SCHEMBL950536; SR-05000002435; SDCCGMLS-0066908.P001; 2-hydroxy-4-methoxy-6-methylbenzoic acid methyl ester; Methyl everninate; CHEMBL1595401; METHYL EVERNINIC ACID; Methyl 2-hydroxy-4-methoxy-6-methylbenzoate #; 2-hydroxy-4-methoxy-6-methyl-benzoic acid methyl ester; KBio3_001208; Methyl 4-methoxy-6-methylsalicylate; AC1LC8Q4; Benzoic acid, 2-hydroxy-4-methoxy-6-methyl-, methyl ester; BSPBio_001708; CCG-38673; 2-Hydroxy-4-methoxy-6-methylbenzoic acid methyl ester; SR-05000002435-1; Spectrum3_000264; NCGC00095818-02; methyl 2-hydroxy-4-methoxy-6-methyl-benzoate; NCGC00095818-01; BRD-K31477169-001-01-3	C10H12O4	196.2 g/mol	CC1=CC(=CC(=C1C(=O)OC)O)OC
TCMBANKIN028214	Decarine	decarine; AIDS-342572; AIDS342572; [1,3]Benzodioxolo[5,6-c]phenanthridin-2-ol, 1-methoxy-; 54354-62-0	C19H13NO4	319.31	COC1=C(C=CC2=C3C=CC4=CC5=C(C=C4C3=NC=C21)OCO5)O
TCMBANKIN028763	Zanthomuuro-lanine		C37H45NO5	583.8 g/mol	CC(C)C1CCC(C2C1C=C(CC2)CC3C4=C(C=CC(=C4OC)OC)C5=C(N3C)C6=CC7=C(C=C6C=C5)OCO7)(C)OC
TCMBANKIN029102	[(Z)-3-(2, 3,4-Trimethoxyphenyl)acrylic acid
TCMBANKIN029129	7-demethyl-6-methoxy-5,6-dihydrochelerythrine		C21H19NO5	365.38
TCMBANKIN029526	rhodojaponinIII	UNII-C7FEJ7QWQE; LMPR0104180003; C7FEJ7QWQE; rhodojaponin iii; 2beta,3beta-epoxy-grayanotpxane-5beta,6beta,10alpha,14beta,16beta-pentol; 26342-66-5; MolPort-039-339-095; ZINC100383069; CHEMBL3763486; Rhodojaponin III; Rhodojaponin-III	C20H32O6	368.46	CC1(C2C(O2)C3C1(C(CC45CC(C(C4O)CCC5C3(C)O)(C)O)O)O)C
TCMBANKIN030691	Zanthocadiuauine A
TCMBANKIN031498	chelerythrine methanolate		C22H21NO5	381.46	CN1CC2=C(C=CC(=C2OC)OC)C3=C1C4=CC5=C(C=C4C(=C3)OC)OCO5
TCMBANKIN031525	OXYNITIDINE	ZINC01721695; 2,3-dimethoxy-12-methyl[1,3]benzodioxolo[5,6-c]phenanthridin-13(12h)-one; 548-31-2; oxynitidine; ZINC1721695; 6-oxynitidine; DTXSID40203275; CHEMBL488611; NSC 135066; AC1L3YUI; AC1Q6PAY; 2,3-dimethoxy-12-methyl-[1,3]benzodioxolo[5,6-c]phenanthridin-13-one; NSC135066; NSC-135066; (1,3)Benzodioxolo(5,6-c)phenanthridin-13(12H)-one, 2,3-dimethoxy-12-methyl-; 2,3-Dimethoxy-12-methyl-12H-[1,3]dioxolo-[4',5':4,5]benzo[1,2-c]phenanthridin-13-one; CTK1H1768; 16,17-DIMETHOXY-21-METHYL-5,7-DIOXA-21-AZAPENTACYCLO[11.8.0.0(2),(1)?.0?,?.0(1)?,(1)?]HENICOSA-1(13),2,4(8),9,11,14,16,18-OCTAEN-20-ONE	C21H17NO5	363.36	CN1C2=C(C=CC3=CC4=C(C=C32)OCO4)C5=CC(=C(C=C5C1=O)OC)OC
TCMBANKIN033029	Coral dish lactone
TCMBANKIN034504	5-(methoxymethyl)-2-furoic acid	5-(methoxymethyl)furan-2-carboxylic acid; 5-Methoxymethyl-furan-2-carboxylic acid; BAS 01558170; 5-(methoxymethyl)-2-furancarboxylic acid; ST5254267	C7H8O4	156.14 g/mol	COCC1=CC=C(O1)C(=O)O
TCMBANKIN034780	Capillarin	ACon1_002077; 3-(2-Butynyl)-1H-2-benzopyran-1-one; 3-but-2-ynylisochromen-1-one; 3-but-2-ynyl-1-isochromenone; 3570-28-3; MLS000863656; 1H-2-Benzopyran-1-one, 3-(2-butynyl)-; MEGxp0_001548; capillarin; SMR000440751	C13H10O2	198.22	CC#CCC1=CC2=CC=CC=C2C(=O)O1
TCMBANKIN035737	Horsfieldi		C20H20O6		COC1=C(C=C(C=C1)C2C3COC(C3CO2)C4=CC5=C(C=C4)OCO5)O
TCMBANKIN036837	vitexin	49513_FLUKA; vitexin ; vitexin-7-olate anion; Flavone, 8-D-glucosyl-4',5,7-trihydroxy-; 5,7-dihydroxy-2-(4-hydroxyphenyl)-8-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-methylol-tetrahydropyran-2-yl]chromone; vitexin-7-olate; vitex-in; 5,7-dihydroxy-2-(4-hydroxyphenyl)-8-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]chromen-4-one; 8-beta-D-Glucopyranosyl-apigenin; 521-33-5; CHEBI:16954; 8-beta-D-Glucopyranosyl-5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one; Vitexin; vitexin-7-olate(1-); 5,7-dihydroxy-2-(4-hydroxyphenyl)-8-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl]-4-chromenone; Apigenin 8-C-glucoside; 8C-hexosyl apigenin; (1S)-1,5-anhydro-1-[5-hydroxy-2-(4-hydroxyphenyl)-7-oxido-4-oxo-4H-chromen-8-yl]-D-glucitol; CHEBI:57963; (1S)-1,5-anhydro-1-[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-8-yl]-D-glucitol; 4H-1-Benzopyran-4-one, 5,7-dihydroxy-8-beta-D-glucopyranosyl-2-(4-hydroxyphenyl)-; 4H-1-Benzopyran-4-one, 5,7-dihydroxy-8-.beta.-D- glucopyranosyl-2-(4-hydroxyphenyl)-; 8-C-beta-glucopyranosylapigenin; 4H-1-Benzopyran-4-one, 8-beta-D-glucopyranosyl-5,7-dihydroxy-2-(4-hydroxyphenyl)-; NCGC00163642-01; C01460; EINECS 222-963-8; 5,7-dihydroxy-2-(4-hydroxyphenyl)-8-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]chromen-4-one; vitexin anion; 3681-93-4; AIDS026705; AIDS-026705	C21H20O10	432.378	c1([H])c(C2=C([H])C(c3c(c([C@]4([H])O[C@]([H])(C([H])([H])O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]4([H])O[H])c(O[H])c([H])c3O[H])O2)=O)c([H])c([H])c(O[H])c1[H]
TCMBANKIN036863	hesperidin	Hesperetin 7-O-rutinoside; Flavanone, 3',5,7-trihydroxy-4'-methoxy-, 7-(6-O-alpha-L-rhamnosyl-delta-glucoside) (7CI); (2S)-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyl-2-tetrahydropyranyl]oxymethyl]-2-tetrahydropyranyl]oxy]-4-chromanone; 15512-51-3; Hesperitin-7-rhamnoglucoside; (2S)-5-hydroxy-2-(3-hydroxy-4-methoxy-phenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyl-oxan-2-yl]oxymethyl]oxan-2-yl]oxy-chroman-4-one; Hesperetin-rutinosid; 5-Hydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-((6-O-alpha-L-rhamnopyranosyl-beta-D-glucopyranosyl)oxy)-4-chromanon; 520-26-3; CHEBI:28775; (S)-7-[[6-O-(6-Deoxy-.alpha.-L-mannopyranosyl)-.beta.-D-glucopyranosyl]oxy]-2,3-dihydro-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-4H-1-benzopyran-4-one; (2S)-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxychroman-4-one; 5-18-05-00218 (Beilstein Handbook Reference); hesperidin ; BSPBio_000619; Hesperidin; BRN 0075140; Atripliside B; 7-((6-O-(6-Deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl)oxy)-2,3-dihydro-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-4H-1-benzopyran-4-one, (S)-; D01038; BCBcMAP01_000136; 3',5'-Dihydroxy-4'-methoxy-7-rutinosyloxyflavan-4-on; 7-(6-O-Desoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyloxy)-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-4-chromanon; (2S)-5-hydroxy-2-(3-hydroxy-4-methoxy-phenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyl-tetrahydropyran-2-yl]oxymethyl]tetrahydropyran-2-yl]oxy-chroman-4-one; CCRIS 3940; Flavanone, 3',5,7-trihydroxy-4'-methoxy-, 7-(6-O-a-L-rhamnosyl-D-glucoside) (7CI); Glucopyranoside, hesperetin-7 6-O-(6-deoxy-alpha-L-mannopyranosyl)-, beta-D-; NSC 44184; (S)-(--)-hesperidin; (2S)-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-4-oxo-3,4-dihydro-2H-chromen-7-yl 6-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranoside; Prestwick3_000400; 106904-63-6; 28283-75-2; Hesperidine; C09755; AIDS-001414; 16643-24-6; SMP1_000149; Ciratin; Hesperetin, 7-(6-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranoside); Hesperidin (JAN); 17654-22-7; 32737-61-4; 4H-1-Benzopyran-4-one, 7-((6-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl)oxy)-2,3-dihydo-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-, (S)-; Hesperetin-rutinoside; EINECS 208-288-1; STOCK1N-12322; AIDS001414; BPBio1_000681; 30927-97-0; Hesper bitabs; 4H-1-Benzopyran-4-one, 7-((6-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl)oxy)-2,3-dihydro-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-, (2S)-; (2S)-Hesperidin	C28H34O15	611	C([H])([H])([H])[C@]1([H])O[C@@]([H])(OC([H])([H])[C@]2([H])O[C@]([H])(Oc3c([H])c(O[C@@]([H])(c4c([H])c([H])c(OC([H])([H])[H])c(O[H])c4[H])C([H])([H])C5=O)c5c(O[H])c3[H])[C@@]([H])(O[H])[C@]([H])(O[H] )[C@@]2([H])O[H])[C@]([H])(O[H])[C@]([H])(O[H])[C@@]1([H])O[H]
TCMBANKIN036880	diosmin	520-27-4; C10039; 5-hydroxy-2-(3-hydroxy-4-methoxy-phenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyl-tetrahydropyran-2-yl]oxymethyl]tetrahydropyran-2-yl]oxy-chromen-4-one; 4H-1-Benzopyran-4-one, 7-((6-O-(6-deoxy-.alpha.-L-mannopyranosyl)-.beta.- D-glucopyranosyl)oxy)-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-; Diosmin [INN]; Diosmetin 7-O-rutinoside; AIDS059330; Diosmine [INN-French]; 5-hydroxy-2-(3-hydroxy-4-methoxy-phenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyl-oxan-2-yl]oxymethyl]oxan-2-yl]oxy-chromen-4-one; Diosminum [INN-Latin]; 5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyl-2-tetrahydropyranyl]oxymethyl]-2-tetrahydropyranyl]oxy]-4-chromenone; AIDS-059330; Diosmin [INN-Spanish]; 4H-1-Benzopyran-4-one, 7-((6-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl)oxy)-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-; 5-hydroxy-2-(3-hydroxy-4-methoxy-phenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyl-tetrahydropyran-2-yl]oxymethyl]tetrahydropyran-2-yl]oxy-chromone; CCRIS 7915; SMP1_000183; EINECS 208-289-7; 5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxychromen-4-one; D3908; diosmin ; Diosmin; STOCK1N-14729	C28H32O15	608.5 g/mol	CC1C(C(C(C(O1)OCC2C(C(C(C(O2)OC3=CC(=C4C(=C3)OC(=CC4=O)C5=CC(=C(C=C5)OC)O)O)O)O)O)O)O)O
TCMBANKIN036882	coptisine	Y0053; BDBM50030257; C19H14NO4; UNII-0GCL71VN14; AK198733; HSDB 8323; CHEMBL362071; Coptisine sulfate; 6020-18-4 (chloride); DTXSID10188404; XYHOBCMEDLZUMP-UHFFFAOYSA-N; AC1Q701I; Coptisine; alkaloid; C16938; HY-N0430; N1737; Bis[1,3]benzodioxolo[5,6-a:4',5'-g]quinolizinium,6,7-dihydro-; 1198398-71-8; 0GCL71VN14; MEGxp0_001731; N2494; Q-100421; LS-44700; AC1L2HUS; KPT; CHEBI:67862; bis[methylenedioxy]protoberberine; I14-18844; NCI60_000465; 6,7-Dihydro[1,3]dioxolo[4,5-G][1,3]dioxolo[7,8]isoquino[3,2-A]isoquinolin-5-Ium; FT-0689356; FT-0645075; ZINC1709414; 3486-66-6; 7,8,13,13a-Tetradehydro-2,3-9,10-bis(methylenedioxy)berbinium; AKOS015903291; Bis(1,3)benzodioxolo(5,6-a:4',5'-g)quinolizinium, 6,7-dihydro-; Coptisin; SCHEMBL156866; Bis[1,3]benzodioxolo[5,6-a:4',5'-g]quinolizinium, 6,7-dihydro-; 348C666; MolPort-020-005-796	C19H14NO4	321	c12c(OC([H])([H])O1)c([H])c3c(C([H])([H])C([H])([H])N(C([H])=C(C([H])=C(OC([H])([H])O4)C4=C5[H])C5=C6[H])=C36)c2[H]
TCMBANKIN039229	Oxychelerythrine	28342-33-8; AKOS032948933; LS-52943; AC1L3UTW; 1,2-dimethoxy-12-methyl-[1,3]benzodioxolo[5,6-c]phenanthridin-13-one; ZINC900932; DTXSID70182584; SCHEMBL10633372; Dihydrooxochelerythrine; 1,2-Dimethoxy-12-methyl-(1,3)benzodioxolo(5,6-c)phenanthridin-13(12H)-one; C12225; BRN 0345198; MolPort-039-338-210; CCRIS 3805; CHEBI:31141; 17,18-DIMETHOXY-21-METHYL-5,7-DIOXA-21-AZAPENTACYCLO[11.8.0.0(2),(1)?.0?,?.0(1)?,(1)?]HENICOSA-1,3,8,10,12,14(19),15,17-OCTAEN-20-ONE; (1,3)Benzodioxolo(5,6-c)phenanthridin-13(12H)-one, 1,2-dimethoxy-12-methyl- (9CI); oxychelerythrine; Oxycheleritrine; [1,3]Benzodioxolo[5,6-c]phenanthridin-13(12H)-one,1,2-dimethoxy-12-methyl-; Chelerythrine, 12,13-dihydro-13-oxo-; 6-Oxochelerythrine; 4-27-00-06655 (Beilstein Handbook Reference); 7,8-dimethoxy-2,3-methylenedioxy-5-methylbenzo [c]phenanthridin-6(5h)-one; (1,3)Benzodioxolo(5,6-c)phenanthridin-13(12H)-one, 1,2-dimethoxy-12-methyl-	C21H17NO5	363.36	CN1C2=C(C=CC3=CC4=C(C=C32)OCO4)C5=C(C1=O)C(=C(C=C5)OC)OC
TCMBANKIN039623	Rhodojaponin II	Rhodojaponin-II; 26116-89-2; LS-90790; BG01121196; 4,10,15,17-TETRAHYDROXY-5,5,10,15-TETRAMETHYL-7-OXAPENTACYCLO[12.2.1.0(1),(1)(1).0?,?.0?,?]HEPTADECAN-3-YL ACETATE; AC1L54IZ; Rhodojaponin II; Grayanotoxane-5,6,10,14,16-pentol, 2,3-epoxy-, 6-acetate, (2-beta,3-beta,6-beta,14R)-; 7,9a-Methano-9aH-cyclopenta(b)heptalene-4,8,11,11a,12(1H)-pentol, 2,3-epoxydodecahydro-1,1,4,8-tetramethyl-, 11-acetate, (2R,3S,3as,4R,4ar,7R,8R,9as,11R,11aR,12R)-		410.5 g/mol
TCMBANKIN041484	rhodomollein xi		C22H36O8	428.5 g/mol	CC(=O)OC1CC23CC(C(C2O)CCC3C(C4C1(C(C(C4O)O)(C)C)O)(C)O)(C)O
TCMBANKIN041510	psi-Rhodomyrtoxin	DTXSID70331671; CHEBI:10635; AC1L9BXW; ZINC00897895; C08951; 2-methyl-1-[1,3,7,9-tetrahydroxy-2,8-dimethyl-6-(3-methylbutanoyl)dibenzofuran-4-yl]butan-1-one; psi-rhodomyrtoxin; 24563-20-0; Pseudorhodomyrtoxin	C24H28O7	428.5 g/mol	CCC(C)C(=O)C1=C(C(=C(C2=C1OC3=C2C(=C(C(=C3C(=O)CC(C)C)O)C)O)O)C)O
TCMBANKIN041606	Nivalenol	C06080; nivalenol; 23282-20-4	C15H20O7	312.32	CC1=CC2C(C(C1=O)O)(C3(C(C(C(C34CO4)O2)O)O)C)CO
TCMBANKIN041825	Chelidimerine	Chelidimerine	C43H34N2O9	720.72	c12c(c([H])c([H])c(c([H])c(OC([H])([H])O3)c3c4[H])c14)c5c(c(OC([H])([H])O6)c6c([H])c5[H])C([H])([H])[N@@H]2(C([H])([H])C(=O)C([H])([H])[N@@H]7(C([H])([H])[H])c(c(c([H])c(OC([H])([H])O8)c8c9[H])c9c([H] )c%10[H])c%10c(c([H])c([H])c(OC([H])([H])O%11)c%11%12)c%12C7([H])[H])C([H])([H])[H]
TCMBANKIN043084	Rhodomollein XIII			412.5 g/mol
TCMBANKIN043327	rhodomollein xii		C22H34O7	410.5 g/mol	CC(=O)OC1CC23CC(C(C2O)CCC3C(=C)C4C1(C(C(C4O)O)(C)C)O)(C)O
TCMBANKIN044655	Rhodomollein IX			368.5 g/mol
TCMBANKIN044671	Rhodomollein XIV			386.5 g/mol
TCMBANKIN046094	Oxyterihanine			349.36
TCMBANKIN046456	rhodomoside a				CC1(C(CC2C1(C(CC34CC(C(C3O)CCC4C2=C)(C)O)O)O)OC5C(C(C(C(O5)CO)O)O)O)C
TCMBANKIN046972	Rhodojaponin VI	BRN 4264514; Rhodojaponin VI; AC1L54SH; LS-73116; Grayanotoxane-2,3,5,6,10,14,16-heptol, (3-beta,6-beta,14R)-		386.5 g/mol
TCMBANKIN049446	kalmanol	(2ar,3r,4as,6r,6ar,8s,9as,10r,10ar)-3,7,7,10-tetramethyltetradecahydrocyclopenta[5,6]cycloocta[1,2,3-cd]pentalene-3,4a,6,6a,8,10-hexol; 118997-92-5; AC1L4OZX; Cyclopenta[5,6]cycloocta[1,2,3-cd]pentalene-3,4a,6,6a,8,10-hexol,tetradecahydro-3,7,7,10-tetramethyl-, (2aR,3R,4aS,6R,6aR,8S,9aS,10R,10aR,10bR)-; AC1Q59O0; CTK4B1000; Cyclopenta(5,6)cycloocta(1,2,3-cd)pentalene-3,4a,6,6a,8,10-hexol, tetradecahydro-3,7,7,10-tetramethyl-, (2aR-(2aalpha,3alpha,4aalpha,6beta,6abeta,8beta,9aalpha,10alpha,10abeta,10balpha))-; Kalmanol	C20H34O6	370.48	CC1(C(CC2C1(C(CC3(CC(C4C3C(C2(C)O)CC4)(C)O)O)O)O)O)C
TCMBANKIN049957	rhodomoside b
TCMBANKIN050158	rhodomollein x		C20H32O6	368.5 g/mol	CC1=CC23CC(C4(C(C(C(C4(C)C)O)O)C(C2CCC1C3O)(C)O)O)O
TCMBANKIN057998	magnoflorine	NSC150447; AKOS025401511; Magnoflorine; Escholine Iodide; C20H24NO4.I; Magnoflorine, iodide; Thalictrine Iodide; Magnoflorine Iodide (6CI,7CI); N2506; AC-20269; 4H-Dibenzo(de,g)quinolinium, 5,6,6a,7-tetrahydro-1,11-dihydroxy-2,10-dimethoxy-6,6-dimethyl-, iodide, (S)-; Magnoflorine-iodide; NSC 150447; MAGNOFLORINE IODIDE; MAGNOFLORINE IODIDE, (+)-(RG); Magnoflorineiodide; BG01755204; (+)-Magnoflorine Iodide; CHEMBL494052; Corytuberine Methiodide; MolPort-006-069-296; NSC-150447; 4277-43-4; (+)-MAGNOFLORINE IODIDE; 1,11-Dihydroxy-2,10-dimethoxy-6-methyl-6a; AK608288; A-aporphinium Iodide; 8167AH; DTXSID00195420; (6aS)-5,6,6a,7-Tetrahydro-1,11-dihydroxy-2,10-dimethoxy-6,6-dimethyl-4H-dibenzo[de,g]quinolinium Iodide; magnoflorine; (+)-magnoflorine	C20H24NO4+	342.4 g/mol	C[N+]1(CCC2=CC(=C(C3=C2C1CC4=C3C(=C(C=C4)OC)O)O)OC)C
TCMBANKIN058002	fagaridine	isofagaridine	C20H16NO4+	334.3 g/mol	C[N+]1=C2C(=C3C=CC(=C(C3=C1)O)OC)C=CC4=CC5=C(C=C42)OCO5
TCMBANKIN058003	sanguinarine	Sanguinarine, 8CI); NSC-59270; sanguinarine ; NSC-35607; [1,6-c]-1,3-dioxolo[4,5-i]phenanthridinium, 13-methyl-, nitrate,sanguiritrin	C20H14NO4+	332.3 g/mol	C[N+]1=C2C(=C3C=CC4=C(C3=C1)OCO4)C=CC5=CC6=C(C=C52)OCO6
TCMBANKIN058188	PHB	NSC4961; AE-848/32195059; AIDS-018038; AI3-01003; 4-Hydroxybenzoic acid; Benzoic acid, p-hydroxy-; ST5210584; 54630_FLUKA; C00156; 4-HBA; InChI=1/C7H6O3/c8-6-3-1-5(2-4-6)7(9)10/h1-4,8H,(H,9,10; Acido p-idrossibenzoico [Italian]; HSDB 7233; 99-96-7; p-Salicylic acid; p-Oxybenzoesaure [German]; HYDROXYBENZOIC ACID, PARA; NSC 4961; Benzoic acid, p-hydroxy; EINECS 202-804-9; CHEBI:30763; p-Hydroxybenzoic acid; H20059_ALDRICH; 240141_ALDRICH; NCGC00166040-01; Kyselina 4-hydroxybenzoova [Czech]; 4-Carboxyphenol; Benzoic acid, 4-hydroxy; W398608_ALDRICH; 4-Hydroxybenzoesaeure; Benzoic acid, 4-hydroxy-; AIDS018038; WLN: QVR DQ; 4-hydroxybenzoic; 4-hydroxy benzoic acid	C7H6O3	138.12 g/mol	C1=CC(=CC=C1C(=O)O)O
TCMBANKIN058658	Micheline B	CCRIS 1549; Oxoushinsunin; C09567; 475-75-2; 8H-Benzo(g)-1,3-benzodioxolo(6,5,4-de)quinolin-8-one; Spermatheridin; NCI60_001798; MEGxp0_001521; BRN 0273167; Spermatheridine; Noraporphin-7-one, 4,5,6,6a-tetradehydro-1,2-(methylenedioxy)-; NSC93681; NSC215254; Liriodenine; Oxoushinsunine; NSC 215254; 8H-Benzo[g]-1,3-benzodioxolo[6,5,4-de]quinolin-8-one; Ushinsunine, oxo-; NORAPORPHIN-7-ONE, 4,5,6,6a-TETRAHYDRO-1,2-(METHYLENEDIOXY)-; 8H-Benzo(g)-1,3-benzodioxolo(6,5,4-de)quinolin-8-one (9CI); AIDS-008761; AIDS008761; NCI60_042088; NSC 93681; 4-27-00-06585 (Beilstein Handbook Reference)	C17H9NO3	275.26 g/mol	C1OC2=C(O1)C3=C4C(=C2)C=CN=C4C(=O)C5=CC=CC=C53
TCMBANKIN058905	phel-lopterin	CHEMBL452751; CHEBI:80887; 4-Methoxy-9-[(3-methyl-2-butenyl)oxy]-7H-furo[3,2-g]chromen-7-one #; 4-methoxy-9-(3-methylbut-2-enoxy)furo[3,2-g]chromen-7-one; ZINC1559986; FT-0698105; C17047; 2543-94-4; 4-methoxy-9-(3-methylbut-2-enoxy)-7-furo[3,2-g][1]benzopyranone; HMS2203M11; 7H-Furo(3,2-g)(1)benzopyran-7-one, 4-methoxy-9-((3-methyl-2-butenyl)oxy)-; 4-Methoxy-9-[(3-methyl-2-butenyl)oxy]-7H-furo[3,2-g]chromen-7-one; SMR000156210; PHELLOPTERIN(P); 4CN-3199; AK163810; 4-methoxy-9-(3-methylbut-2-enoxy)-7-furo[3,2-g]chromenone; cid_98608; 7H-Furo[3,2-g][1]benzopyran-7-one, 4-methoxy-9-[(3-methyl-2-butenyl)oxy]-; HMS3356N05; MolPort-009-015-193; NCGC00247535-02!4-methoxy-9-(3-methylbut-2-enoxy)furo[3,2-g]chromen-7-one; 4-METHOXY-9-[(3-METHYLBUT-2-EN-1-YL)OXY]FURO[3,2-G]CHROMEN-7-ONE; BDBM81058; NSC 152469; SCHEMBL2468854; NSC152469; NCGC00247535-01; MLS000574895; AE-641/05533037; DTXSID30180086; ST24048894; AC1L40AH; Phelloterin; 7H-Furo[3,2-g][1]benzopyran-7-one,4-methoxy-9-[(3-methyl-2-buten-1-yl)oxy]-; MCULE-3441916605; NSC-152469; phellopterin; AC1Q6AY6; BMLZFLQMBMYVHG-UHFFFAOYSA-N; AKOS024465013	C17H16O5	300.3 g/mol	CC(=CCOC1=C2C(=C(C3=C1OC(=O)C=C3)OC)C=CO2)C
TCMBANKIN059002	Grayanotoxin I	ACon0_000384; 135912-EP2277880A1; MEGxp0_001761; Acetylandromedol; (3beta,6beta,14R)-Grayanotoxane-3,5,6,10,14,16-hexol, 14-acetate; G-I; NP-010017; NCGC00168796-02_C22H36O7_Grayanotoxane-3,5,6,10,14,16-hexol, 14-acetate, (3beta,6beta,14R,16alpha)-; GRAYANOTOXIN I; ZINC3978484; NCGC00168796-01; Grayanotoxane-3,5,6,10,14,16-hexol 14-acetate; 4720/9/6; SCHEMBL3229044; GTX-I; 7,9a-Methano-9aH-cyclopenta(b)heptalene-2,4,8,11,11a,12(1H)-hexol-, dodecahydro-1,1,4,8-tetramethyl-, 12-acetate, (2S,3aS,4aR,7R,8R,9aS,11R,11aR,12R)-; HSDB 3463; 135912-EP2292610A1; Rhodotoxine; Rhodotoxin; Asebotoxin; W4E6HC3T2B; BRN 2065643; Perhydro-2beta,4alpha,8alpha,11beta,11abeta-pentahydroxy-1,1,4,8-tetramethyl-7,9a-methano-9aalphaH-cyclopenta(b)heptalen-12beta-yl acetat; Andromedotoxin; UNII-W4E6HC3T2B; CHEMBL3085397; Grayanotoxane-3,5,6,10,14,16-hexol, 14-acetate, (3beta,6beta,14R)- (9CI); ACon1_000099; AKOS027326735; CHEBI:5542; AK322338; Perhydro-2beta,4alpha,8alpha,11beta,11abeta-pentahydroxy-1,1,4,8-tetramethyl-7,9a-methano-9aalphaH-cyclopenta(b)heptalen-12beta-yl acetate; 7,9a-Methano-9aH-cyclopenta(b)heptalene-2,4,8,11,11a,12(1H)-hexol, dodecahydro-1,1,4,8-tetramethyl-, 12-acetate (2S,3as,4R,4ar,7R,8R,9as,11R,11aR,12R)-; NSC 26711; (14R)-3beta,5,6beta,10,16-pentahydroxygrayanotoxan-14-yl acetate; C09103; 4720-09-6	C22H36O7	412.5 g/mol	CC(=O)OC1C2CCC3C1(CC(C4(C(C3(C)O)CC(C4(C)C)O)O)O)CC2(C)O
TCMBANKIN059012	rhodomollein xi;rhodomolleinIII	rhodomollein iii	C22H36O8	428.5 g/mol	CC(=O)OC1CC23CC(C(C2O)CCC3C(C4C1(C(C(C4O)O)(C)C)O)(C)O)(C)O
TCMBANKIN059461	rhodomollein ii; grayanotoxin ii; grayanotoxine II		C20H32O5	352.5 g/mol	CC1(C(CC2C1(C(CC34CC(C(C3O)CCC4C2=C)(C)O)O)O)O)C
TCMBANKIN059614	Amyrin		C30H50O	426.72	CC1(CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)C)O)C)C)C2C1)C)C)C
TCMBANKIN059804	5alpha-O-(3'-Methylamino-3'-phenylpropionyl)nicotaxine			716.9	CC1=C2C(C(C3(CCC(C4(C3C(C(C2(C)C)CC1=O)OC(=O)C)CO4)OC(=O)CC(C5=CC=CC=C5)NC)C)OC(=O)C6=CN=CC=C6)OC(=O)C
TCMBANKIN060072	oxypaeoniflorin		C23H28O12	496.46	CC12CC3(C4CC1(C4(C(O2)O3)COC(=O)C5=CC=C(C=C5)O)OC6C(C(C(C(O6)CO)O)O)O)O
TCMBANKIN060693	Sitogluside		C35H60O6	576.85g/mol	CCC(CCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)OC5C(C(C(C(O5)CO)O)O)O)C)C)C(C)C
TCMBANKIN061292	chelidimerine		C43H32N2O9	720.72	CN1C(C2=C(C=CC3=C2OCO3)C4=C1C5=CC6=C(C=C5C=C4)OCO6)CC(=O)CC7C8=C(C=CC9=C8OCO9)C1=C(N7C)C2=CC3=C(C=C2C=C1)OCO3
TCMBANKIN061403	Abiol	AIDS209944; Methyl Parasept; H3647_SIGMA; Methyl p-hydroxybenzoate; BRN 0509801; FEMA Number 2710; p-Methoxycarbonylphenol; 4-HYDROXY-BENZOIC ACID METHYL ESTER; Benzoic acid, p-hydroxy-, methyl ester; Nipagin M; 4-Hydroxybenzoic acid, methyl ester; Nipagin; p-Oxybenzoesauremethylester [German]; D01400; Methyl chemosept; p-Hydroxybenzoic methyl ester; 4-(Methoxycarbonyl)phenol; Tegosept M; 4-10-00-00360 (Beilstein Handbook Reference); Aseptoform; H6654_SIAL; Methyl 4-hydroxybenzoate; Maseptol; BENZOIC ACID,4-HYDROXY,METHYL ESTER; AI3-01336; NCGC00159376-02; Methylparaben (TN); Metaben; Methyl-p-hydroxybenzoate; 99-76-3; Preserval M; Methylparaben (NF); Methyl parahydroxybenzoate (JP15); ST5214511; p-Hydroxybenzoic acid methyl ester; CCRIS 3946; Methyl ester of p-hydroxybenzoic acid; Methylparaben; p-Hydroxybenzoic acid, methyl ester; Caswell No. 573PP; FEMA No. 2710; NCGC00159376-03; p-Carbomethoxyphenol; Methylben; 47889_SUPELCO; NSC3827; ZINC00001712; AIDS-209944; Preserval; HSDB 1184; Metoxyde; Methaben; Moldex; WLN: QR DVO1; 4-Hydroxybenzoic acid methyl ester; InChI=1/C8H8O3/c1-11-8(10)6-2-4-7(9)5-3-6/h2-5,9H,1H; Solbrol M; Methylparaben [USAN]; 54752_FLUKA; Benzoic acid, 4-hydroxy-, methyl ester; Methyl parahydroxybenzoate; component of Heb-Cort MC; 54750_FLUKA; NSC406127; Methyl Butex; Solbrol; Methyl paraben; Paridol; EINECS 202-785-7; M8911_SIAL; Methyl p-oxybenzoate; NSC 3827; W271004_ALDRICH; EPA Pesticide Chemical Code 061201; Methyl parahydroxybenzoate (TN); Methylester kyseliny p-hydroxybenzoove [Czech]; Septos; methyl p-hydroxybenzoate; 4-hydroxybenzoic acid methyl ester; methyl-4-hydroxybenzoate; Methyl paraben; methylparaben	C8H8O3	152.15 g/mol	COC(=O)C1=CC=C(C=C1)O
TCMBANKIN061489	Diosmetin	C10038; 520-34-3; AIDS-214630; KBioGR_001586; 5,7-dihydroxy-2-(3-hydroxy-4-methoxy-phenyl)chromen-4-one; SpecPlus_000435; Spectrum3_000987; Spectrum_001505; SDCCGMLS-0066783.P001; diosmetin; ST5331610; 5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-4H-chromen-4-one; Spectrum4_001113; DivK1c_006531; 4H-1-Benzopyran-4-one, 5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-; KBio1_001475; 3',5,7-trihydroxy-4'-methoxy flavone; 5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chromen-4-one; SPBio_001735; Spectrum5_001707; KBioSS_001985; KBio2_004553; AIDS214630; KBio2_001985; NCGC00163540-01; EINECS 208-291-8; KBio2_007121; 5,7-Dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-4-benzopyrone; Luteolin 4'-methyl ether; KBio3_001873; 5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-4-chromenone; CHEBI:4630; 3',5,7-trihydroxy-4'-methoxyflavone; Spectrum2_001638; BSPBio_002653; 5,7-dihydroxy-2-(3-hydroxy-4-methoxy-phenyl)chromone; 5,7,3'-trihydroxy-4'-methoxyflavone	C16H12O6	300.26 g/mol	COC1=C(C=C(C=C1)C2=CC(=O)C3=C(C=C(C=C3O2)O)O)O
TCMBANKIN061695	Majudin	Spectrum2_000534; 5-19-06-00004 (Beilstein Handbook Reference); 4-methoxyfuro[3,2-g]chromen-7-one; Spectrum3_000663; KBio3_001545; CCRIS 4348; KBioGR_002055; 4-methoxy-7-furo[3,2-g]chromenone; DivK1c_000529; NCGC00091582-01; 7H-Furo[3,2-g][1]benzopyran-7-one, 4-methoxy-; KBio2_001274; TNP00299; NINDS_000529; Bergapten; Spectrum5_000155; EINECS 207-604-5; KBio1_000529; 4-Methoxy-7H-furo(3,2-g)(1)benzopyran-7-one; KBioSS_001274; ACon0_000984; AIDS031096; 4-methoxy-7H-furo[3,2-g]chromen-7-one; HSDB 3466; 5-Methoxypsoralen; Spectrum_000794; KBio2_003842; BSPBio_002325; MEGxp0_000990; 65320_FLUKA; BRN 0019560; 5-Mop; 6-Hydroxy-4-methoxy-5-benzofuranacrylic acid, gamma-lactone; NCGC00091582-02; Bergaptene; 5-Methoxy psoralen; NCI60_042121; 5-Methoxy-6,7-furanocoumarin; KBio2_006410; 4-Methoxy-furo[3,2-g]chromen-7-one; IDI1_000529; Bergapten(e); BAS 00674110; ACon1_001979; SPBio_000547; 5-Methoxypsoralen with ultraviolet A therapy; BERGAPTAN; Psoraderm; SDCCGMLS-0066492.P001; NSC95437; 7H-Furo(3,2-g)(1)benzopyran-7-one, 4-methoxy-; ST057259; ZINC00057731; InChI=1/C12H8O4/c1-14-12-7-2-3-11(13)16-10(7)6-9-8(12)4-5-15-9/h2-6H,1H; C01557; Heraclin; NCGC00091582-03; 4-Methoxyfuro[3,2-g]benzopyrane-7-one; 275727_ALDRICH; Spectrum4_001478; SPECTRUM300546; O-Methylbergaptol; 5-Methoxyfuranocoumarin; NSC 95437; NCGC00017357-01; AIDS-031096; 484-20-8; Oprea1_562364; 5-methoxypsoralen; bergapten;5-19-06-00004 (Beilstein Handbook Reference); AB00052148_06; V0122; DivK1c_000529; NCGC00259906-01; KBio2_001274; EINECS 207-604-5; Geralen; SR-05000002173; KBio1_000529; KBioSS_001274; Majudin; 4-Methoxy-7H-furo[3,2-g]chromen-7-one #; 4-Methoxy-7H-furo[3,2-g]chromen-7-one; HMS501K11; 5-Methoxypsoralen, 99%; SMR000112435; NCGC00017357-03; NCGC00017357-07; CAS-484-20-8; B2840; AK134854; KS-00000GSD; TR-017690; Bergapten(e); NCGC00017357-04; BAS 00674110; CC-24574; C-11626; BERGAPTAN; Psoraderm; D07521; SDCCGMLS-0066492.P001; BRD-K12968785-001-03-4; MLS002207272; 5-Methoxypsoralen (Bergapten); InChI=1/C12H8O4/c1-14-12-7-2-3-11(13)16-10(7)6-9-8(12)4-5-15-9/h2-6H,1H; Bergaptene (DCF); 5-methoxy-psoralen; Pentaderm (TN); SPECTRUM300546; HY-N0370; ANW-42611; 5-Methoxypsoralen (obsol.); 5-Methoxy psoralen; KBioGR_002055; Oprea1_562364; Tox21_303255; NCGC00178705-02; Q-100536; Spectrum3_000663; BRD-K12968785-001-02-6; 4-methoxy-7H-furo[3,2-g][1]benzopyran-7-one; NCGC00017357-08; 7H-Furo[3,2-g][1]benzopyran-7-one, 4-methoxy-; ZINC57731; TNP00299; Bergapten; BDBM50067880; Spectrum5_000155; NSC755877; 4-Methoxy-7H-furo(3,2-g)(1)benzopyran-7-one; AB00052148_07; DS-2970; Spectrum_000794; KBio2_003842; 5-methoxy-2H-furo[3,2-g]chromen-2-one; BRN 0019560; NCGC00178705-01; 5-Mop; UNII-4FVK84C92X; M-9412; NCGC00091582-02; HMS2268M24; CHEBI:18293; CS-2234; 5 methoxypsoralen; 5-methoxypsoralen ; 5-Methoxy-6,7-furanocoumarin; KBio2_006410; NCGC00017357-05; SR-05000002173-5; CCG-39946; 5-Methoxypsoralen with ultraviolet A therapy; DSSTox_CID_5560; NSC95437; CJ-00484; 7H-Furo(3,2-g)(1)benzopyran-7-one, 4-methoxy-; ST057259; 6-Hydroxy-4-methoxy-5-benzofuranacrylic acid, .gamma.-lactone; NCGC00017357-02; N1304; AC1Q47BC; NCGC00091582-03; SBI-0051583.P002; 4-Methoxy-7H-furo[3,2-g]benzopyran-7-one; NSC 95437; 5-methoxyfurano[3,2-g]chromen-2-one; bergaptene; 484-20-8; CTK3J2399; s4239; Spectrum2_000534; Pentaderm; 4FVK84C92X; KBio3_001545; HMS3652F19; ST2411501; NINDS_000529; STK333038; MCULE-7768334865; NCGC00017357-06; HSDB 3466; 5-Methoxypsoralen; BSPBio_002325; CB-1199; 6-Hydroxy-4-methoxy-5-benzofuranacrylic acid, gamma-lactone; BGEBZHIAGXMEMV-UHFFFAOYSA-N; I14-13388; MFCD00010272; bmse000758; IDI1_000529; AB0019675; DB12216; 4-Methoxyfuro[3,2-g]benzopyrane-7-one; 4-Methoxyfuro[3,2-g]benzopyran-7-one; O-Methylbergaptol; 484B208; RTR-017690; NCGC00091582-04; SC-46077; AKOS000276715; SR-05000002173-3; CCRIS 4348; DSSTox_GSID_25560; 4-methoxyfuro[3,2-g]chromen-7-one; ZB002242; DTXSID1025560; NSC-755877; NCGC00091582-01; 5-methoxypsoralene; AX8014410; A827532; AJ-09777; ACon0_000984; Tox21_202357; HMS1923G13; FT-0603416; MEGxp0_000990; AC1L1DHU; MolPort-000-880-879; NSC-95437; 4CN-0945; NCI60_042121; BG01521510; 4-Methoxy-furo[3,2-g]chromen-7-one; NCGC00256998-01; AC-20189; CHEMBL24171; SPBio_000547; ACon1_001979; DSSTox_RID_77830; 7H-Furo[3, 4-methoxy-; SR-05000002173-2; Bergapten, analytical standard; SCHEMBL50066; 4-methoxy-7-furo[3,2-g][1]benzopyranone; Heraclin; C01557; Bio-0829; Spectrum4_001478; LS-1292; D0QR5G; Pharmakon1600-00300546; 5-Methoxyfuranocoumarin; MLS002454380; NCGC00017357-01; AN-9448	C12H8O4	216.19 g/mol	COC1=C2C=CC(=O)OC2=CC3=C1C=CO3
TCMBANKIN061698	Dictamine	Spectrum3_000101; SPECTRUM100541; C10660; Furo(2,3-b)quinoline, 4-methoxy-; dictamnine; Furo[2,3-b]quinoline, 4-methoxy-; KBio2_006213; NCGC00095429-01; SDCCGMLS-0066336.P001; Dictamnine; CCRIS 1583; Spectrum2_000349; Oprea1_294767; KBio3_000802; 484-29-7; Spectrum4_001383; dictamine ; Oprea1_134081; DivK1c_006140; SPBio_000417; SpecPlus_000044; 4-methoxyfuro[2,3-b]quinoline; Spectrum_000597; KBio2_003645; KBioSS_001077; BSPBio_001682; KBio2_001077; dictamine; KBioGR_001706; KBio1_001084; Spectrum5_000086; 4-27-00-02030 (Beilstein Handbook Reference); BRN 0176932;Spectrum3_000101; SPECTRUM100541; AC1L2901; LS-70926; C10660; Furo(2,3-b)quinoline, 4-methoxy-; DTXSID0041012; Furo[2,3-b]quinoline, 4-methoxy-; MCULE-6817939774; MolPort-003-665-620; C12H9NO2; AM-331/20711025; KBio2_006213; CTK4J0807; NCGC00095429-01; AKOS006274709; SDCCGMLS-0066336.P001; Dictamnine; Furo[2,3-b]quinoline,4-methoxy-; NCGC00095429-02; CCRIS 1583; FT-0686595; Spectrum2_000349; Oprea1_294767; V0176; KBio3_000802; 4-Methoxyfuro[2,3-b]quinoline #; 484-29-7; Spectrum4_001383; BRD-K29178788-001-01-2; 4-Methoxyfuro[2,3-b]quinoline; CCG-38624; Oprea1_134081; DivK1c_006140; SR-05000002442; Q-100537; WIONIXOBNMDJFJ-UHFFFAOYSA-N; SPBio_000417; SR-05000002442-1; SpecPlus_000044; CS-3267; Spectrum_000597; N2224; 484D297; CHEBI:4512; KBio2_003645; BSPBio_001682; KBioSS_001077; HQZ3798D0A; Diktaminin; SCHEMBL1760700; Dictamine; CHEMBL22533; VU0243862-3; HY-N0849; KBio2_001077; KBioGR_001706; UNII-HQZ3798D0A; HMS3561L11; AN-45222; 4-Methoxy-furo[2,3-b]quinoline; ZINC265517; AC1Q4FDA; KBio1_001084; Spectrum5_000086; 4-27-00-02030 (Beilstein Handbook Reference); BRN 0176932	C12H9NO2	199.21	COC1=C2C=COC2=NC3=CC=CC=C31
TCMBANKIN061745	syringic acid; Syryngic; 1,5-dimethoxy-3-hydroxybenzoicacid; 3,5-dimethoxy-4-hydroxybenzoic acid; Cedar acid	I01-1212; syringicacid; 3,5-dimethoxy-4-oxidanyl-benzoate; CHEBI:132111; 4-hydroxy-3,5-dimethoxybenzoate; c1409; ZB006317; AKOS015888648; A824548; A829374; CJ-01507; AC1OC351; ST51051575; C10833; DivK1c_006581; KBio3_002814; 530-57-4; AI3-24376; 3,5-Dimethoxy-4-hydroxybenzyl acid; S6881_SIGMA; BSPBio_003312; InChI=1/C9H10O5/c1-13-6-3-5(9(11)12)4-7(14-2)8(6)10/h3-4,10H,1-2H3,(H,11,12; EINECS 208-486-8; Gallic acid 3,5-dimethyl ether; Syringic acid; NSC2129; Spectrum3_001866; 4-10-00-01995 (Beilstein Handbook Reference); 4-Hydroxy-3,5-dimethoxybenzoic acid; SpecPlus_000485; NSC 2129; 4-hydroxy-3,5-dimethoxy-benzoic acid; Spectrum5_000963; ST5214746; KBio1_001525; BRN 2115262; 3,5-Dimethoxy-4-hydroxybenzoic acid; Benzoic acid, 4-hydroxy-3,5-dimethoxy-	C9H10O5	198.17 g/mol	COC1=CC(=CC(=C1O)OC)C(=O)O
TCMBANKIN061762	syringaresinol	(+)-Suyringaresinol-di-O-beta-D-glucoside_qt; (+)syringaresinol; (+)-Suyringaresinol-di-O-beta-D-glucoside; liriodendrin_qt; dl-Syringaresinol; syringaresinol diglucoside_qt; dl-sy-ringaresinol; (+)-syringaresinol-O-β-D-glucopyranoside; (+ )-syringaresinol; 4-[(1S,3aR,4S,6aR)-4-(4-hydroxy-3,5-dimethoxy-phenyl)-1,3,3a,4,6,6a-hexahydrofuro[4,3-c]furan-1-yl]-2,6-dimethoxy-phenol; 21453-69-0; C10889; (7alpha,7'alpha,8alpha,8'alpha)-3,3',5,5'-tetramethoxy-7,9':7',9-diepoxylignane-4,4'-diol; CHEBI:47; 4-[(1S,3aR,4S,6aR)-4-(4-hydroxy-3,5-dimethoxyphenyl)-1,3,3a,4,6,6a-hexahydrofuro[4,3-c]furan-1-yl]-2,6-dimethoxyphenol; (+)-syringaresinol; (+ )- syringaresinol; dl-syringaresinol; (-)-syringaresinol; episyringaresinol; (+)-syringarosinol; (+ )-Syringaresinol-O-β-D-glucopyranoside; syringaresino; (-)-syringaresinol; (?)-syringaresinol; (+)-Syringaresinol; lirioresinol-A	C34H46O18	742.72	COC1=CC(=CC(=C1O)OC)C2C3COC(C3CO2)C4=CC(=C(C(=C4)OC)O)OC
TCMBANKIN061810	DMBQ;2,6-dimethoxybenzoquinone	2,6-Dimethoxysemiquinone radicals; KBioSS_001203; SPECTRUM200413; 2,6-Dimethoxybenzo-1,4-quinone; 2,6-Dimethoxy-p-quinone; Spectrum_000723; NCGC00095215-02; Spectrum2_000781; DIMETHOXYBENZOQUINONE,2,6-; Spectrum4_001608; NCGC00095215-01; 2,6-Dimethoxybenzoquinone; ghl.PD_Mitscher_leg0.4; ZINC00137119; Maybridge1_002628; SDCCGMLS-0066389.P001; 2,5-Cyclohexadiene-1,4-dione, 2,6-dimethoxy-, radical ion(1-); NSC 24500; EINECS 208-484-7; NCI60_001958; 2,6-dimethoxycyclohexa-2,5-diene-1,4-dione; KBio2_006339; 2,6-Dimethoxyquinone; BSPBio_001673; DivK1c_001380; ST5331798; p-Benzoquinone, 2,6-dimethoxy-; Spectrum5_000335; 2,5-Cyclohexadiene-1,4-dione, 2,6-dimethoxy- (9CI); 2,5-Cyclohexadiene-1,4-dione, 2,6-dimethoxy-; KBio2_001203; C10331; 2,6-Dimethoxysemiquinone anions; CDS1_000340; NSC24500; KBio3_001173; NSC56336; 26547-64-8; 2,6-Dimethoxy-p-benzoquinone; AIDS011961; 2,6-Dimethoxy-1,4-benzoquinone; SPBio_000882; KBio2_003771; Spectrum3_000177; 428566_ALDRICH; 530-55-2; KBioGR_001955; AIDS-011961	C8H8O4	168.15 g/mol	COC1=CC(=O)C=C(C1=O)OC
TCMBANKIN061827	ethoxychelerythrine;lysionotin	13-ethoxy-1,2-dimethoxy-12-methyl-13H-[1,3]benzodioxolo[5,6-c]phenanthridine; BG01680984; SCHEMBL13103363; 20-ETHOXY-17,18-DIMETHOXY-21-METHYL-5,7-DIOXA-21-AZAPENTACYCLO[11.8.0.0(2),(1)?.0?,?.0(1)?,(1)?]HENICOSA-1,3,8,10,12,14(19),15,17-OCTAENE; Y0019; AC1NSV9I; 12,13-Dihydro-13-ethoxy-1,2-dimethoxy-12-methyl[1,3]benzodioxolo[5,6-c]phenanthridine; FT-0723636;ACon1_000159; 5,7-Dihydroxy-6,8-dimethoxy-2-(4-methoxyphenyl)-4H-1-benzopyran-4-one; 5,7-dihydroxy-6,8-dimethoxy-2-(4-methoxyphenyl)chromen-4-one; 5,7-dihydroxy-6,8-dimethoxy-2-(4-methoxyphenyl)chromone; C10111; ACon0_001112; AIDS035341; Lysionotin; MEGxp0_001862; 4H-1-Benzopyran-4-one, 5,7-dihydroxy-6,8-dimethoxy-2-(4-methoxyphenyl)-; 5,7-dihydroxy-6,8-dimethoxy-2-(4-methoxyphenyl)-4-chromenone; AIDS-035341; 10176-66-6;ethoxychelerythrine;lysionotin	C18H16O7	344.3 g/mol	COC1=CC=C(C=C1)C2=CC(=O)C3=C(C(=C(C(=C3O2)OC)O)OC)O
TCMBANKIN061892	limettin	HMS501D13; MolPort-003-665-736; AC1L1EFT; 5-18-03-00199 (Beilstein Handbook Reference); ACMC-1AM7E; C-10266; A827593; BSPBio_003016; CTK4J0961; NCGC00254844-01; HMS1921E18; Coumarin derivative, 2a; KBio2_003291; AI3-36094; LS-55181; CC-20975; 5,7-Dimethoxy-2H-1-benzo-pyran-2-one; Citropten, analytical standard; AK167951; 5,7-Dimethoxy-2-benzopyrone; DB-051575; DivK1c_000391; CAS-487-06-9; NSC217987; FT-0619848; SR-05000002446-1; NINDS_000391; ST50319835; Spectrum_000243; Tox21_300942; InChI=1/C11H10O4/c1-13-7-5-9(14-2)8-3-4-11(12)15-10(8)6-7/h3-6H,1-2H3; DTXSID1041421; Limettin; NCGC00094841-02; MCULE-8767481325; TC-168439; AQ-358/43417403; NCGC00178344-01; SMR000112321; OR345352; MLS002703744; SDCCGMLS-0066597.P001; KB-73158; IDI1_000391; 5,7-dimethoxy-coumarin; NSC102793; 2H-1-Benzopyran-2-one, 5,7-dimethoxy-; 9155AF; CHEMBL481049; 5,7-Dimethoxy-2H-1-benzopyran-2-one; Spectrum5_001348; SCHEMBL516577; DSSTox_CID_21421; 5,7-Dimethoxy-2H-chromen-2-one; citropten; EINECS 207-646-4; I14-52904; MLS002472928; DSSTox_GSID_41421; CCG-40277; HMS2268I06; NXJCRELRQHZBQA-UHFFFAOYSA-; NSC 102793; KBioGR_001222; AKOS015915990; KBio2_000723; 487D069; KBio2_005859; Spectrum3_001398; CHEBI:113528; BRD-K78612426-001-02-6; COUMARIN, 5,7-DIMETHOXY-; AN-45243; Citraptene; NCGC00094841-03; Spectrum2_000814; 5, 7-Dimethoxycoumarin; NCGC00094841-01; 5,7-dimethoxychromen-2-one; Spectrum4_000781; BDBM93217; KBio3_002236; NSC-102793; JWE1QQ247N; Limetin; 5,7-Dimethyloxy-2H-1-benzopyran-2-one; CCRIS 3595; NSC-217987; DSSTox_RID_79725; 487-06-9; SPECTRUM1500707; NXJCRELRQHZBQA-UHFFFAOYSA-N; SR-05000002446; Citroptene; 2H-1-Benzopyran-2-one,5,7-dimethoxy-; SPBio_000707; 5,7-dimethoxy-1-benzopyran-2-one; 5,7-Dimethoxycoumarin, 98%; UNII-JWE1QQ247N; KBio1_000391; ZINC57754; AC-20780; 5,7-Dimethoxy-chromen-2-one; NCGC00094841-04; 5,7-Dimethoxycoumarin; 2H-1-Benzopyran-2-one,7-dimethoxy-; MLS002207304; KBioSS_000723; MFCD00006870; BRN 0187066; ZB002255; Coumarin,7-dimethoxy-; citropten; Limetin; 5, 7- dimethoxy coumarin; HMS501D13; MolPort-003-665-736; AC1L1EFT; 5-18-03-00199 (Beilstein Handbook Reference); ACMC-1AM7E; C-10266; A827593; BSPBio_003016; CTK4J0961; NCGC00254844-01; HMS1921E18; Coumarin derivative, 2a; KBio2_003291; AI3-36094; LS-55181; CC-20975; 5,7-Dimethoxy-2H-1-benzo-pyran-2-one; Citropten, analytical standard; AK167951; 5,7-Dimethoxy-2-benzopyrone; DB-051575; DivK1c_000391; CAS-487-06-9; NSC217987; FT-0619848; SR-05000002446-1; NINDS_000391; ST50319835; Spectrum_000243; Tox21_300942; InChI=1/C11H10O4/c1-13-7-5-9(14-2)8-3-4-11(12)15-10(8)6-7/h3-6H,1-2H3; DTXSID1041421; Limettin; NCGC00094841-02; MCULE-8767481325; TC-168439; AQ-358/43417403; NCGC00178344-01; SMR000112321; OR345352; MLS002703744; SDCCGMLS-0066597.P001; KB-73158; IDI1_000391; 5,7-dimethoxy-coumarin; NSC102793; 2H-1-Benzopyran-2-one, 5,7-dimethoxy-; 9155AF; CHEMBL481049; 5,7-Dimethoxy-2H-1-benzopyran-2-one; Spectrum5_001348; SCHEMBL516577; DSSTox_CID_21421; 5,7-Dimethoxy-2H-chromen-2-one; EINECS 207-646-4; I14-52904; MLS002472928; DSSTox_GSID_41421; CCG-40277; HMS2268I06; NXJCRELRQHZBQA-UHFFFAOYSA-; NSC 102793; KBioGR_001222; AKOS015915990; KBio2_000723; 487D069; KBio2_005859; Spectrum3_001398; CHEBI:113528; BRD-K78612426-001-02-6; COUMARIN, 5,7-DIMETHOXY-; AN-45243; Citraptene; NCGC00094841-03; Spectrum2_000814; 5, 7-Dimethoxycoumarin; NCGC00094841-01; 5,7-dimethoxychromen-2-one; Spectrum4_000781; BDBM93217; KBio3_002236; NSC-102793; JWE1QQ247N; Limetin; 5,7-Dimethyloxy-2H-1-benzopyran-2-one; CCRIS 3595; NSC-217987; DSSTox_RID_79725; 487-06-9; SPECTRUM1500707; NXJCRELRQHZBQA-UHFFFAOYSA-N; SR-05000002446; Citroptene; 2H-1-Benzopyran-2-one,5,7-dimethoxy-; SPBio_000707; 5,7-dimethoxy-1-benzopyran-2-one; 5,7-Dimethoxycoumarin, 98%; UNII-JWE1QQ247N; KBio1_000391; ZINC57754; AC-20780; 5,7-Dimethoxy-chromen-2-one; NCGC00094841-04; 5,7-Dimethoxycoumarin; 2H-1-Benzopyran-2-one,7-dimethoxy-; MLS002207304; KBioSS_000723; MFCD00006870; BRN 0187066; ZB002255; Coumarin,7-dimethoxy-; Spectrum5_001348; AIDS026325; 5,7-Dimethoxy-2-benzopyrone; ZINC00057754; EINECS 207-646-4; CCRIS 3595; DivK1c_000391; NSC217987; NINDS_000391; 487-06-9; SPECTRUM1500707; Spectrum_000243; ST5319835; Citroptene; Limettin; SPBio_000707; CITROPTEN; NCGC00094841-02; 5-18-03-00199 (Beilstein Handbook Reference); NSC 102793; KBio1_000391; KBioGR_001222; 116238_ALDRICH; BSPBio_003016; KBio2_000723; KBio2_005859; Spectrum3_001398; 5,7-Dimethoxycoumarin; AIDS-026325; AI3-36094; KBio2_003291; SDCCGMLS-0066597.P001; IDI1_000391; Citraptene; 5,7-dimethoxy-2-chromenone; KBioSS_000723; Spectrum2_000814; 5,7-dimethoxy-coumarin; BRN 0187066; NSC102793; 2H-1-Benzopyran-2-one, 5,7-dimethoxy-; 5,7-dimethoxychromen-2-one; Coumarin, 5,7-dimethoxy-; Spectrum4_000781; NCGC00094841-01; KBio3_002236	C11H10O4	206.19 g/mol	COC1=CC2=C(C=CC(=O)O2)C(=C1)OC

植物对应的疾病

疾病ID	病名	疾病类型	MeSH	参考文献

植物对应的靶点

靶点ID	基因名	基因别名	描述	染色体位置	Map_Location	基因类型

TCMBank_ID:

TCMBANKHE000810

ID:

TCMBANKHE000810

植物拉丁名:

Radix Zanthoxyli

功能与主治:

To promote the flow of qi, relieve pain, to eliminate blood stasis, to promote blood circulation and dispel wind./Treatment of traumatic injury, rheumatic arthralgia, stomach-ache, teethache, bitten by venomous snake, applied for burn caused by hot liquid or fire.

药用植物名:

两面针

药味:

Mild; Pungent; Bitter

经络:

Stomach; Liver

毒性:

Toxic

治疗类型:

祛风湿散寒药

TCM_ID_id:

7091

SymMap_id:

245

TCMSP_id:

454